GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
3

3D Medicines 1244.HK · HKD

Health Care · HKEX · 🇭🇰 Hong Kong

Compare

2.58

-1.15%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

3D Medicines — daily HKEX:1244

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View 3D Medicines on TradingView ↗
Market value
HK$666.1m
Last close × shares
Volume
1k
Shares, 9 Nov 2026

About 3D Medicines

Its shares trade on HKEX under the ticker 1244.HK. It has been listed since 15 December 2022. In the fiscal year to 31 December 2025, it reported revenue of CN¥356.1m and a net loss of CN¥177.5m. At that date it held total assets of CN¥936.6m and shareholders' equity of CN¥597.0m.

3D Medicines, Inc. is an investing holding company, which focuses on the development and commercialization of immuno-oncology (I/O) therapies with differentiated clinical benefit in response to the trend of treating cancer as a chronic disease. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2022-12-15. The firm focuses on the discovery, development and commercialization of innovative drugs in the field of cancer chronic disease treatment, and also lays out the field of cancer pain management. The firm has built a complete set of internal R&D systems, and has covered the entire process from drug discovery, preclinical development, clinical trials, and registration. The firm's first marketed drug, Envafolimab, is a subcutaneously injected PD-L1 inhibitor for the treatment of pan-tumor types. The firm also has a number of innovative drug research and development pipelines. The firm primarily operates in the domestic Chinese market.

Figures and description from our data supplier, not checked against the company's own report.

More about 3D Medicines →

Latest on 3D Medicines

Our reporting

We have not reported on 3D Medicines yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is 3D Medicines's ticker?

3D Medicines trades as 1244.HK on HKEX, under ISIN KYG8872R1011.

What was 3D Medicines's last closing price?

2.58 on 9 Nov 2026. The figure is in HKD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.